Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis

The introduction of new therapies for the treatment of multiple sclerosis (MS) is a very recent phenomenon and little is known of their mechanism of action. Moreover, the response is subject to interindividual variability and may be affected by genetic factors, such as polymorphisms in the genes imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarzuelo Romero, María José, Pérez Ramírez, Cristina, Carrasco Campos, María Isabel, Sánchez Martín, Almudena, Calleja Hernández, Miguel Ángel, Ramírez Tortosa, María Carmen, Jiménez Morales, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146426/
https://www.ncbi.nlm.nih.gov/pubmed/33922540
http://dx.doi.org/10.3390/jpm11050335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146426/
https://www.ncbi.nlm.nih.gov/pubmed/33922540
http://dx.doi.org/10.3390/jpm11050335

Ejemplares similares